Russell Investments Group, Ltd. Agios Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 2,779 shares of AGIO stock, worth $108,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,779

Previous 5,818 52.23%

Holding current value

$108,436

Previous $250,000 50.8%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$41.19 - $49.72 $125,176 - $151,099	-3,039 Reduced 52.23%	2,779 $123,000
Q2 2024 Aug 08, 2024	BUY	$27.55 - $48.83 $141,799 - $251,328	5,147 Added 767.06%	5,818 $250,000
Q1 2024 May 08, 2024	BUY	$21.32 - $34.81 $1,428 - $2,332	67 Added 11.09%	671 $19,000
Q4 2023 Feb 05, 2024	SELL	$19.97 - $24.53 $32,730 - $40,204	-1,639 Reduced 73.07%	604 $13,000
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $17,344 - $20,064	-712 Reduced 24.09%	2,243 $55,000
Q2 2023 Aug 10, 2023	SELL	$21.38 - $29.19 $1 Million - $1.37 Million	-46,885 Reduced 94.07%	2,955 $83,000
Q1 2023 May 09, 2023	BUY	$21.74 - $30.93 $262,358 - $373,263	12,068 Added 31.95%	49,840 $1.14 Million
Q4 2022 Feb 08, 2023	BUY	$24.81 - $31.52 $109,809 - $139,507	4,426 Added 13.27%	37,772 $1.06 Million
Q3 2022 Nov 04, 2022	SELL	$19.51 - $34.14 $110,094 - $192,652	-5,643 Reduced 14.47%	33,346 $942,000
Q2 2022 Jul 29, 2022	SELL	$17.06 - $31.42 $79,294 - $146,040	-4,648 Reduced 10.65%	38,989 $862,000
Q1 2022 May 05, 2022	SELL	$26.68 - $34.81 $399,212 - $520,862	-14,963 Reduced 25.53%	43,637 $1.27 Million
Q4 2021 Jan 21, 2022	SELL	$29.58 - $49.78 $1.44 Million - $2.42 Million	-48,694 Reduced 45.38%	58,600 $1.93 Million
Q3 2021 Nov 08, 2021	SELL	$41.92 - $58.18 $1.36 Million - $1.89 Million	-32,553 Reduced 23.28%	107,294 $4.95 Million
Q2 2021 Aug 04, 2021	BUY	$52.06 - $61.27 $1.23 Million - $1.45 Million	23,588 Added 20.29%	139,847 $7.7 Million
Q1 2021 May 10, 2021	SELL	$44.23 - $57.5 $1.49 Million - $1.94 Million	-33,678 Reduced 22.46%	116,259 $6 Million
Q4 2020 Feb 08, 2021	BUY	$33.21 - $46.54 $1.8 Million - $2.53 Million	54,335 Added 56.83%	149,937 $6.5 Million
Q3 2020 Nov 09, 2020	BUY	$33.87 - $55.93 $1.85 Million - $3.06 Million	54,736 Added 133.94%	95,602 $3.34 Million
Q2 2020 Aug 05, 2020	BUY	$34.45 - $53.48 $1.39 Million - $2.16 Million	40,381 Added 8325.98%	40,866 $2.18 Million
Q1 2020 May 06, 2020	BUY	$31.52 - $53.81 $15,287 - $26,097	485 New	485 $17,000
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $5,263 - $7,763	-114 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$42.73 - $76.53 $6,964 - $12,474	-163 Reduced 58.84%	114 $5,000
Q1 2018 May 11, 2018	BUY	$59.83 - $86.53 $13,880 - $20,074	232 Added 515.56%	277 $23,000
Q4 2017 Feb 06, 2018	SELL	$52.12 - $72.33 $68,746 - $95,403	-1,319 Reduced 96.7%	45 $3,000
Q3 2017 Nov 07, 2017	BUY	$54.89 - $67.12 $74,869 - $91,551	1,364	1,364 $91,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.14B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Agios Pharmaceuticals, Inc. Transaction History